Blog Posts

A High-Level Hearing on the Future of the EU’s Pharmaceutical Legislation – European Cancer Organisation

ECO/LinkedIn

Jul 12, 2025, 15:15

A High-Level Hearing on the Future of the EU’s Pharmaceutical Legislation – European Cancer Organisation

European Cancer Organisation shared on LinkedIn:

“This week in Strasbourg

The European Parliament’s Intergroup on Cancer and Rare Diseases held a high-level hearing on the future of the EU’s pharmaceutical legislation.

The session was co-chaired MEPs Stine Bosse, Tilly Metz, Alessandra Moretti, Tomislav Sokol, and Vlad Voiculescu.

Policymakers, medical professionals and patient advocates came together to discuss the legislation, including presentations from representatives of the ECO community:

Denis Lacombe, CEO of the European Organisation for Research and Treatment of Cancer, on the topic of treatment optimisation, and
Lydie Meheus from the Anticancer Fund on the topic of drug repurposing.

Next step The EU Parliament, Council, and Commission will negotiate the final text.

Read more about the hearing in the official press release.”

More posts featuring ECO.

Alessandra Moretti cancer Denis Lacombe ECO European Parliament’s Intergroup Lydie Meheus OncoDaily Oncology rare diseases Stine Bosse Tilly Metz Tomislav Sokol Vlad Voiculescu

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding